ZE74-0282 is a novel JAK2 JH2 domain inhibitor with promising preclinical activity in JAK2V617F mutant diseases

Dec 22

Written By Guest User

ZE74-0282 is a novel JAK2 JH2 domain inhibitor with promising preclinical activity in JAK2V617F mutant diseases

Download Poster

Guest User

Discovery of a novel, selective brain penetrant CDK2 inhibitor for targeted cancer therapy